277 related articles for article (PubMed ID: 16536485)
1. Identification of CD21-binding peptides with phage display and investigation of binding properties of HPMA copolymer-peptide conjugates.
Ding H; Prodinger WM; Kopecek J
Bioconjug Chem; 2006; 17(2):514-23. PubMed ID: 16536485
[TBL] [Abstract][Full Text] [Related]
2. Two-step fluorescence screening of CD21-binding peptides with one-bead one-compound library and investigation of binding properties of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugates.
Ding H; Prodinger WM; Kopecek J
Biomacromolecules; 2006 Nov; 7(11):3037-46. PubMed ID: 17096529
[TBL] [Abstract][Full Text] [Related]
3. Biorecognition of HPMA copolymer-adriamycin conjugates by lymphocytes mediated by synthetic receptor binding epitopes.
Omelyanenko V; Kopecková P; Prakash RK; Ebert CD; Kopecek J
Pharm Res; 1999 Jul; 16(7):1010-9. PubMed ID: 10450924
[TBL] [Abstract][Full Text] [Related]
4. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
[TBL] [Abstract][Full Text] [Related]
5. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro.
Omelyanenko V; Kopecková P; Gentry C; Shiah JG; Kopecek J
J Drug Target; 1996; 3(5):357-73. PubMed ID: 8866655
[TBL] [Abstract][Full Text] [Related]
6. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
Line BR; Mitra A; Nan A; Ghandehari H
J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells.
Xiang Q; Yang Y; Zhou Z; Zhou D; Jin Y; Zhang Z; Huang Y
Eur J Pharm Biopharm; 2012 Feb; 80(2):379-86. PubMed ID: 22101181
[TBL] [Abstract][Full Text] [Related]
8. Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes.
Tang A; Kopeiková P; Kopeckevá J
Pharm Res; 2003 Mar; 20(3):360-7. PubMed ID: 12669954
[TBL] [Abstract][Full Text] [Related]
9. Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21).
Prodinger WM; Schwendinger MG; Schoch J; Köchle M; Larcher C; Dierich MP
J Immunol; 1998 Nov; 161(9):4604-10. PubMed ID: 9794388
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates.
Tijerina M; Kopecková P; Kopecek J
Photochem Photobiol; 2003 Jun; 77(6):645-52. PubMed ID: 12870851
[TBL] [Abstract][Full Text] [Related]
11. HPMA copolymer-aminohexylgeldanamycin conjugates targeting cell surface expressed GRP78 in prostate cancer.
Larson N; Ray A; Malugin A; Pike DB; Ghandehari H
Pharm Res; 2010 Dec; 27(12):2683-93. PubMed ID: 20845065
[TBL] [Abstract][Full Text] [Related]
12. Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.
Kovacs JM; Hannan JP; Eisenmesser EZ; Holers VM
J Biol Chem; 2009 Apr; 284(14):9513-20. PubMed ID: 19164292
[TBL] [Abstract][Full Text] [Related]
13. Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma.
Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R
J Drug Target; 1996; 3(5):385-90. PubMed ID: 8866657
[TBL] [Abstract][Full Text] [Related]
14. Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting.
Mitra A; Coleman T; Borgman M; Nan A; Ghandehari H; Line BR
J Control Release; 2006 Aug; 114(2):175-83. PubMed ID: 16889865
[TBL] [Abstract][Full Text] [Related]
15. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R
Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433
[TBL] [Abstract][Full Text] [Related]
16. Identification of peptides targeting the surface of Plasmodium falciparum-infected erythrocytes using a phage display peptide library.
Eda K; Eda S; Sherman IW
Am J Trop Med Hyg; 2004 Aug; 71(2):190-5. PubMed ID: 15306709
[TBL] [Abstract][Full Text] [Related]
17. Coupling to polymeric scaffolds stabilizes biofunctional peptides for intracellular applications.
Ruttekolk IR; Chakrabarti A; Richter M; Duchardt F; Glauner H; Verdurmen WP; Rademann J; Brock R
Mol Pharmacol; 2011 Apr; 79(4):692-700. PubMed ID: 21247935
[TBL] [Abstract][Full Text] [Related]
18. [Screening peptides binding specifically to large intestinal cancer LoVo cells from phage random peptide library].
Liao KX; Yao XQ; Wu CT; Lin F; Wu WL; Zeng SD; Luo YQ; Lei ST
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):986-90. PubMed ID: 18583245
[TBL] [Abstract][Full Text] [Related]
19. Identification of antibiotic clarithromycin binding peptide displayed by T7 phage particles.
Morimura T; Noda N; Kato Y; Watanabe T; Saitoh T; Yamazaki T; Takada K; Aoki S; Ohta K; Ohshige M; Sakaguchi K; Sugawara F
J Antibiot (Tokyo); 2006 Oct; 59(10):625-32. PubMed ID: 17191677
[TBL] [Abstract][Full Text] [Related]
20. Selection of ceramic fluorapatite-binding peptides from a phage display combinatorial peptide library: optimum affinity tags for fluorapatite chromatography.
Islam T; Bibi NS; Vennapusa RR; Fernandez-Lahore M
J Mol Recognit; 2013 Aug; 26(8):341-50. PubMed ID: 23784990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
